The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Abstract Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arran...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ling‐Long Tang, Yu‐Pei Chen, Chuan‐Ben Chen, Ming‐Yuan Chen, Nian‐Yong Chen, Xiao‐Zhong Chen, Xiao‐Jing Du, Wen‐Feng Fang, Mei Feng, Jin Gao, Fei Han, Xia He, Chao‐Su Hu, De‐sheng Hu, Guang‐Yuan Hu, Hao Jiang, Wei Jiang, Feng Jin, Jin‐Yi Lang, Jin‐Gao Li, Shao‐Jun Lin, Xu Liu, Qiu‐Fang Liu, Lin Ma, Hai‐Qiang Mai, Ji‐Yong Qin, Liang‐Fang Shen, Ying Sun, Pei‐Guo Wang, Ren‐Sheng Wang, Ruo‐Zheng Wang, Xiao‐Shen Wang, Ying Wang, Hui Wu, Yun‐Fei Xia, Shao‐Wen Xiao, Kun‐Yu Yang, Jun‐Lin Yi, Xiao‐Dong Zhu, Jun Ma
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Chinese Society of Clinical Oncology
CSCO
Nasopharyngeal carcinoma
Diagnosis
Staging
Risk
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/d1b3df74dd3845eea72df7182aab876b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d1b3df74dd3845eea72df7182aab876b
record_format dspace
spelling oai:doaj.org-article:d1b3df74dd3845eea72df7182aab876b2021-11-27T06:05:32ZThe Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma2523-354810.1002/cac2.12218https://doaj.org/article/d1b3df74dd3845eea72df7182aab876b2021-11-01T00:00:00Zhttps://doi.org/10.1002/cac2.12218https://doaj.org/toc/2523-3548Abstract Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi‐disciplinary team comprising of experts from all sub‐specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence‐based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow‐up of NPC, which aim to improve the management of NPC.Ling‐Long TangYu‐Pei ChenChuan‐Ben ChenMing‐Yuan ChenNian‐Yong ChenXiao‐Zhong ChenXiao‐Jing DuWen‐Feng FangMei FengJin GaoFei HanXia HeChao‐Su HuDe‐sheng HuGuang‐Yuan HuHao JiangWei JiangFeng JinJin‐Yi LangJin‐Gao LiShao‐Jun LinXu LiuQiu‐Fang LiuLin MaHai‐Qiang MaiJi‐Yong QinLiang‐Fang ShenYing SunPei‐Guo WangRen‐Sheng WangRuo‐Zheng WangXiao‐Shen WangYing WangHui WuYun‐Fei XiaShao‐Wen XiaoKun‐Yu YangJun‐Lin YiXiao‐Dong ZhuJun MaWileyarticleChinese Society of Clinical OncologyCSCONasopharyngeal carcinomaDiagnosisStagingRiskNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancer Communications, Vol 41, Iss 11, Pp 1195-1227 (2021)
institution DOAJ
collection DOAJ
language EN
topic Chinese Society of Clinical Oncology
CSCO
Nasopharyngeal carcinoma
Diagnosis
Staging
Risk
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Chinese Society of Clinical Oncology
CSCO
Nasopharyngeal carcinoma
Diagnosis
Staging
Risk
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ling‐Long Tang
Yu‐Pei Chen
Chuan‐Ben Chen
Ming‐Yuan Chen
Nian‐Yong Chen
Xiao‐Zhong Chen
Xiao‐Jing Du
Wen‐Feng Fang
Mei Feng
Jin Gao
Fei Han
Xia He
Chao‐Su Hu
De‐sheng Hu
Guang‐Yuan Hu
Hao Jiang
Wei Jiang
Feng Jin
Jin‐Yi Lang
Jin‐Gao Li
Shao‐Jun Lin
Xu Liu
Qiu‐Fang Liu
Lin Ma
Hai‐Qiang Mai
Ji‐Yong Qin
Liang‐Fang Shen
Ying Sun
Pei‐Guo Wang
Ren‐Sheng Wang
Ruo‐Zheng Wang
Xiao‐Shen Wang
Ying Wang
Hui Wu
Yun‐Fei Xia
Shao‐Wen Xiao
Kun‐Yu Yang
Jun‐Lin Yi
Xiao‐Dong Zhu
Jun Ma
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
description Abstract Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi‐disciplinary team comprising of experts from all sub‐specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence‐based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow‐up of NPC, which aim to improve the management of NPC.
format article
author Ling‐Long Tang
Yu‐Pei Chen
Chuan‐Ben Chen
Ming‐Yuan Chen
Nian‐Yong Chen
Xiao‐Zhong Chen
Xiao‐Jing Du
Wen‐Feng Fang
Mei Feng
Jin Gao
Fei Han
Xia He
Chao‐Su Hu
De‐sheng Hu
Guang‐Yuan Hu
Hao Jiang
Wei Jiang
Feng Jin
Jin‐Yi Lang
Jin‐Gao Li
Shao‐Jun Lin
Xu Liu
Qiu‐Fang Liu
Lin Ma
Hai‐Qiang Mai
Ji‐Yong Qin
Liang‐Fang Shen
Ying Sun
Pei‐Guo Wang
Ren‐Sheng Wang
Ruo‐Zheng Wang
Xiao‐Shen Wang
Ying Wang
Hui Wu
Yun‐Fei Xia
Shao‐Wen Xiao
Kun‐Yu Yang
Jun‐Lin Yi
Xiao‐Dong Zhu
Jun Ma
author_facet Ling‐Long Tang
Yu‐Pei Chen
Chuan‐Ben Chen
Ming‐Yuan Chen
Nian‐Yong Chen
Xiao‐Zhong Chen
Xiao‐Jing Du
Wen‐Feng Fang
Mei Feng
Jin Gao
Fei Han
Xia He
Chao‐Su Hu
De‐sheng Hu
Guang‐Yuan Hu
Hao Jiang
Wei Jiang
Feng Jin
Jin‐Yi Lang
Jin‐Gao Li
Shao‐Jun Lin
Xu Liu
Qiu‐Fang Liu
Lin Ma
Hai‐Qiang Mai
Ji‐Yong Qin
Liang‐Fang Shen
Ying Sun
Pei‐Guo Wang
Ren‐Sheng Wang
Ruo‐Zheng Wang
Xiao‐Shen Wang
Ying Wang
Hui Wu
Yun‐Fei Xia
Shao‐Wen Xiao
Kun‐Yu Yang
Jun‐Lin Yi
Xiao‐Dong Zhu
Jun Ma
author_sort Ling‐Long Tang
title The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
title_short The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
title_full The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
title_fullStr The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
title_full_unstemmed The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
title_sort chinese society of clinical oncology (csco) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
publisher Wiley
publishDate 2021
url https://doaj.org/article/d1b3df74dd3845eea72df7182aab876b
work_keys_str_mv AT linglongtang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT yupeichen thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT chuanbenchen thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT mingyuanchen thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT nianyongchen thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiaozhongchen thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiaojingdu thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT wenfengfang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT meifeng thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT jingao thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT feihan thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiahe thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT chaosuhu thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT deshenghu thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT guangyuanhu thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT haojiang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT weijiang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT fengjin thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT jinyilang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT jingaoli thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT shaojunlin thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xuliu thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT qiufangliu thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT linma thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT haiqiangmai thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT jiyongqin thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT liangfangshen thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT yingsun thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT peiguowang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT renshengwang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT ruozhengwang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiaoshenwang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT yingwang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT huiwu thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT yunfeixia thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT shaowenxiao thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT kunyuyang thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT junlinyi thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiaodongzhu thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT junma thechinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT linglongtang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT yupeichen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT chuanbenchen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT mingyuanchen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT nianyongchen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiaozhongchen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiaojingdu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT wenfengfang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT meifeng chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT jingao chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT feihan chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiahe chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT chaosuhu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT deshenghu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT guangyuanhu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT haojiang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT weijiang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT fengjin chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT jinyilang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT jingaoli chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT shaojunlin chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xuliu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT qiufangliu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT linma chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT haiqiangmai chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT jiyongqin chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT liangfangshen chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT yingsun chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT peiguowang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT renshengwang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT ruozhengwang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiaoshenwang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT yingwang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT huiwu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT yunfeixia chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT shaowenxiao chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT kunyuyang chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT junlinyi chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT xiaodongzhu chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
AT junma chinesesocietyofclinicaloncologycscoclinicalguidelinesforthediagnosisandtreatmentofnasopharyngealcarcinoma
_version_ 1718409193782771712

Ejemplares similares